Wall St. Cheat Sheet

Alnylam Pharmaceuticals, Inc. (ALNY) Stock News, Earnings & History

(NASDAQ:ALNY) Healthcare

Stocks & Headlines
Insider Trading Cheat Sheet

Enjoy Interactive Tools and Indicators

52wk high: 29.07

52wk low: 9.94

EPS: -1.94

P/E: N/A

Div Rate: N/A

Yield: N/A

Market Cap: 1.80B

Avg Vol (3m): 424,187

Latest Headlines

Alnylam Pharmaceuticals Earnings: Here’s Why Investors are Excited Now

Derek Hoffman | Mon, May 6 | Comment
Jim Cramer: Buy ConAgra, Kimco Realty, and These 2 Stocks

Alex Capel | Thu, Apr 4 | Comment
KeyCorp Downgraded to Sell and 3 Downgraded Stocks to Follow

Alex Capel | Mon, Feb 11 | Comment
BSD Medical Shares Pop, Isis Receives Payment From Alnylam: Healthcare Business Wrap

Mark Lawson | Tue, Oct 23 | Comment
Healthcare Business Update: Merck Pays Milestone to Ligand, Alnylam Partners with Genzyme

Mark Lawson | Mon, Oct 22 | Comment
Healthcare Business Recap: Vivus Director BUYS Its Shares, Humana's New INITIATIVE

Mark Lawson | Thu, Aug 23 | Comment
Healthcare Business Recap: Onyx's Drug Gets APPROVED, Somaxon DIVESTS Shares

Mark Lawson | Fri, Jul 20 | Comment
Biogen ENTERS into Research Collaboration and 4 Stocks Hitting 52-Week Highs

Leah Powell | Wed, Jul 18 | Comment
Alnylam Pharmaceuticals Target RAISED and 1 Stock Analysis to Notice Now

Leah Powell | Tue, Jul 17 | Comment
Authentec CHOSEN for Android Security and 4 Stocks Enjoying 52-Week Highs

Mark Lawson | Tue, Jul 17 | Comment
Healthcare Review: Alnylam Shoots The MOON, Glaxo ACQUIRES Human Genome

Mark Lawson | Mon, Jul 16 | Comment
Applied Materials Target REDUCED and 4 Must-See New Analysis Ratings

Mark Lawson | Wed, Jul 11 | Comment

More Articles About ALNY →

Insider Trading Cheat Sheet

No insider trading data available for Alnylam Pharmaceuticals, Inc..

Wall St. Cheat Sheet has been featured in these fine media outlets:

Yahoo, HV, Market Watch, The Wall St. Journal